Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

Torella L, Klermund J, Bilbao-Arribas M, Tamayo I, Andrieux G, Chmielewski KO, Vales A, Olagüe C, Moreno-Luqui D, Raimondi I, Abad A, Torrens-Baile J, Salido E, Huarte M, Hernaez M, Boerries M, Cathomen T, Zabaleta N, Gonzalez-Aseguinolaza G. 2024. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO Mol Med. 2024 Jan 5. doi: 10.1038/s44321-023-00008-8.

Categorised in:

This post was written by Heike Ufheil